US6339042B1ExpiredUtility
Herbicidal N-cyclohexadienyl heteroaryloxyacetamides
Est. expiryNov 29, 2019(expired)· nominal 20-yr term from priority
C07D 231/22C07D 277/68A01N 43/74C07D 285/13A01N 43/84C07D 257/04C07D 285/08C07D 271/07C07D 263/58C07D 471/04
34
PatentIndex Score
0
Cited by
7
References
16
Claims
Abstract
The novel compounds of formula I: wherein Het represents an optionally substituted, optionally benzofused nitrogen containing 5- or 6-membered heteroaromatic group; R 1 represents an alkyl, alkoxyalkyl or cycloalkyl group; R 2 each independently represent an alkyl or alkenyl group, and m is 0 or an integer from 1 to 6, and herbicidal compositions containing such compounds as active ingredients can be utilized in various agricultural methods.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A compound of the general formula (I)
wherein
Het represents an optionally substituted, optionally benzofused nitrogen containing 5- or 6-membered heteroaromatic group;
R 1 represents an alkyl, alkoxyalkyl or cycloalkyl group;
R 2 each independently represent an alkyl or alkenyl group, and
m represents 0 or an integer from 1 to 6.
2. A compound according to claim 1 wherein R 2 each independently represent a C 1-4 alkyl or group C 2-4 alkenyl and m is 1, 2 or 3.
3. A compound according to claim 1 wherein Het represents a thiadiazolyl, benzoxazolyl or benzothiazolyl group which may be substituted by one or more halogen atoms or alkyl, haloalkyl, haloalkoxy or phenyl groups.
4. A compound according to claim 3 wherein Het represents a group selected from the formulae (1) and (2)
in which
R 3 represents a hydrogen or halogen atom or an alkyl or haloalkyl group;
X represents O or S;
Y represents independently of each other a halogen atom or an optionally substituted alkyl group; and
n is an integer from 0 to 4.
5. A compound according to claim 1 wherein R 2 represents a methyl group and m is 3.
6. A compound as claimed in claim 1 , wherein R 1 represents a C 1-5 alkyl, a cyclopropyl or a 2-methoxyethyl group.
7. A compound of formula IA,
wherein Het, R 1 and R 2 are as defined in claim 1 and the dashed line indicates the presence of two conjugated double bonds in one or the other position with respect to the point of attachment of the nitrogen atom.
8. A compound according to claim 7 selected from the formulae IA1 and IA2,
wherein
R 1 represents an alkyl or alkoxyalkyl group,
Het represents a group selected from the formulae (1) and (2)
in which X has the meaning given, and
Y represents a halogen atom or a methyl group,
n is 0 or 1, and
R 3 represents a C 1-4 alkyl or C 1-4 fluoroalkyl group.
9. An isomeric mixture of the two compounds of formula IA of claim 7 which differ only in the location of the conjugated double bonds.
10. The compounds according to claim 1 selected from the group consisting of
2-(5-trifluoromethyl-[1,3,4]-thiadiazol-2-yloxy)-N-methyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-trifluoromethyl-[1,3,4]-thiadiazol-2-yloxy)-N-ethyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-trifluoromethyl-[1,3,4]-thiadiazol-2-yloxy)-N-methyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-trifluoromethyl-[1,3,4]-thiadiazol-2-yloxy)-N-ethyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-ethyl-[1,3,4]-thiadiazol-2-yloxy)-N-methyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-ethyl-[1,3,4]-thiadiazol-2-yloxy)-N-ethyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-ethyl-[1,3,4]-thiadiazol-2-yloxy)-N-methyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-ethyl-[1,3,4]-thiadiazol-2-yloxy)-N-ethyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-pentafluoroethyl-[1,3,4]-thiadiazol-2-yloxy)-N-methyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-pentafluoroethyl-[1,3,4]-thiadiazol-2-yloxy)-N-ethyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-pentafluoroethyl-[1,3,4]-thiadiazol-2-yloxy)-N-methyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-pentafluoroethyl-[1,3,4]-thiadiazol-2-yloxy)-N-ethyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5- tert-butyl-[1,3,4]-thiadiazol-2-yloxy)-N-methyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5- tert-butyl-[1,3,4]-thiadiazol-2-yloxy)-N-ethyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5- tert-butyl-[1,3,4]-thiadiazol-2-yloxy)-N-methyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5- tert-butyl-[1,3,4]-thiadiazol-2-yloxy)-N-ethyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-trifluoromethyl-[1,3,4]-thiadiazol-2-yloxy)-N-isopropyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-trifluoromethyl-[1,3,4]-thiadiazol-2-yloxy)-N-isopropyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-ethyl-[1,3,4]-thiadiazol-2-yloxy)-N-isopropyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-ethyl-[1,3,4]-thiadiazol-2-yloxy)-N-isopropyl-N-(3, 3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-pentafluoroethyl-[1,3,4]-thiadiazol-2-yloxy)-N-isopropyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-pentafluoroethyl-[1,3,4]-thiadiazol-2-yloxy)-N-isopropyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-tert-butyl-[1,3,4]-thiadiazol-2-yloxy)-N-isopropyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-tert-butyl-[1,3,4]-thiadiazol-2-yloxy)-N-isopropyl-N-(3,3,5-2-(5-trifluoromethyl-[1,3,4]-thiadiazol-2-yloxy)-N-(2-methoxyethyl)-N-(3,5,5-trimethylcyclohexa-1, 3 -dienyl)-acetamide,
2-(5-trifluoromethyl-[1,3,4]-thiadiazol-2-yloxy)-N-(2-methoxyethyl)-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-trifluoromethyl-[1,3,4]-thiadiazol-2-yloxy)-N-cyclopropyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-trifluoromethyl-[1,3,4]-thiadiazol-2-yloxy)-N-cyclopropyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(benzoxazol-2-yloxy)-N-methyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(benzoxazol-2-yloxy)-N-methyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(benzoxazol-2-yloxy)-N-ethyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(benzoxazol-2-yloxy)-N-ethyl- N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(benzoxazol-2-yloxy)-N-isopropyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(benzoxazol-2-yloxy)-N-isopropyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(benzoxazol -2-yloxy)-N-(2-methoxyethyl)-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(benzoxazol-2-yloxy)-N-(2-methoxyethyl)-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-chloro-benzoxazol-2-yloxy)-N-methyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-chloro-benzoxazol-2-yloxy)-N-methyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-chloro-benzoxazol-2-yloxy)-N-ethyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-chloro-benzoxazol-2-yloxy)-N-ethyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-chloro-benzoxazol-2-yloxy)-N-isopropyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-chloro-benzoxazol-2-yloxy)-N-isopropyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(6-chloro-benzoxazol-2-yloxy)-N-methyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(6-chloro-benzoxazol-2-yloxy)-N-methyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(6-chloro-benzoxazol-2-yloxy)-N-ethyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(6-chloro-benzoxazol-2-yloxy)-N-ethyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(benzoxazol-2-yloxy)-N-isopropyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(6-chloro-benzoxazol-2-yloxy)-N-isopropyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-chloro-benzoxazol-2-yloxy)-N-(2-methoxyethyl)-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-chloro-benzoxazol-2-yloxy)-N-(2-methoxyethyl)-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(6-chloro-benzoxazol-2-yloxy)-N-(2-methoxyethyl)-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(6-chloro-benzoxazol-2-yloxy)-N-(2-methoxyethyl)-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-methyl-benzoxazol-2-yloxy)-N-methyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-methyl-benzoxazol-2-yloxy)-N-methyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-methyl-benzoxazol-2-yloxy)-N-ethyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-methyl-benzoxazol-2-yloxy)-N-ethyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-methyl-benzoxazol-2-yloxy)-N-isopropyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-methyl-benzoxazol-2-yloxy)-N-isopropyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(5-methyl-benzoxazol-2-yloxy)-N-(2-methoxyethyl)-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(5-methyl-benzoxazol-2-yloxy)-N-(2-methoxyethyl)-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(benzothiazol-2-yloxy)-N-methyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(benzothiazol-2-yloxy)-N-methyl-N-(3,3,5-trimethylcyclohexa-1,5-enyl)-acetamide,
2-(benzothiazol-2-yloxy)-N-ethyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(benzothiazol-2-yloxy)-N-ethyl-N-(3,3,5-trimethylcyclohexa-1,5-enyl)-acetamide,
2-(benzothiazol-2-yloxy)-N-isopropyl-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(benzothiazol-2-yloxy)-N-isopropyl-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide,
2-(benzothiazol-2-yloxy)-N-(2-methoxyethyl)-N-(3,5,5-trimethylcyclohexa-1,3-dienyl)-acetamide,
2-(benzothiazol-2-yloxy)-N-(2-methoxyethyl)-N-(3,3,5-trimethylcyclohexa-1,5-dienyl)-acetamide.
11. A process for the preparation of a compound according to claim 1 which comprises reacting a compound of the general formula II,
in which R 1 , R 2 and m are defined in claim 1 with a compound of general formula III,
Het—L 2 (III)
wherein Het represents an alkyl, alkoxyalkyl, or cycloalkyl group and one of L 1 and L 2 represents a hydroxy group and the other represents a leaving group.
12. A compound of the general formula II,
in which R 1 represents an alkyl, alkoxyalkyl or cycloalkyl group; R 2 each independently represent an alkyl or alkenyl group,
m represents zero or an integer from 1 to 6, and
L 1 represents a hydroxy group or a leaving group selected from alkyl- and arylsulfonyl, alkyl- and arylsulfonyloxy, and perfluoroalkylsulfonyloxy groups.
13. A herbicidal composition comprising at least one compound according to claim 1 and at least one agronomically acceptable carrier.
14. A composition according to claim 13 comprising at least two carriers, at least one of which is a surface-active agent.
15. A method of combating undesired plant growth at a locus which comprises applying to the locus a herbicidally effective amount of a compound described in claim 1 .
16. A method of combating undesired plant growth at a locus which comprises applying to the locus a herbicidally effective amount of a composition according to claim 13 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.